Home › Funds › Integral Health Asset Management, LLC › IONS

Integral Health Asset Management, LLC position in IONS

IONIS PHARMACEUTICALS INC · Health Care

Integral Health Asset Management, LLC reported holding 300,000 shares of IONS (IONIS PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$23.8M, representing 1.07% of its reported portfolio and ranking #29 among its reported holdings. Integral Health Asset Management, LLC has disclosed IONS holdings in 3 of the last 9 reported quarters, going back to Q2 2024.

Latest position (Q2 2026)300.00K sh
Reported value held$23.79M
Portfolio Weight1.07%
First reportedQ2 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Integral Health Asset Management, LLC's IONS position evolved

Integral Health Asset Management, LLC first disclosed a stake in IONS in Q2 2024 at 250,000 shares (US$11.9M). The position peaked in Q2 2026 at 300,000 shares, worth US$23.8M. Across 3 filings, Integral Health Asset Management, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 300,000 shares valued at US$23.8M — an increase of 175,000 shares quarter over quarter.. Notable position changes include a 140% increase in Q2 2026 (shares fell 44% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 250.00K $11.91M New
Q1 2026 125.00K $9.39M New
Q2 2026 300.00K $23.79M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IONS and 13F data

IONS (IONIS PHARMACEUTICALS INC) is a Health Care company. 42 other funds we track also report a position in IONS — the largest reported positions include Two Sigma Investments (US$495.7M), TWO SIGMA ADVISERS, LP (US$241.5M), Tweedy, Browne Co LLC (US$180.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IONS

All IONS fund holders →

FAQ

How long has Integral Health Asset Management, LLC held IONS?

Integral Health Asset Management, LLC has disclosed IONS holdings in 3 of the last 9 reported quarters, going back to Q2 2024.

What is Integral Health Asset Management, LLC's current position in IONS?

As of Q2 2026, Integral Health Asset Management, LLC holds 300.00K shares of IONS (IONIS PHARMACEUTICALS INC), valued at $23.79M, representing 1.07% of its reported portfolio and ranking #29.

Has Integral Health Asset Management, LLC been buying or selling IONS?

In the latest 13F filing (Q2 2026), Integral Health Asset Management, LLC increased its position in IONS. The position peaked in Q2 2026 at 300.00K shares.

Which other funds hold IONS?

Other major institutional holders of IONS include Two Sigma Investments, TWO SIGMA ADVISERS, LP, Tweedy, Browne Co LLC, among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.